Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 20, 2026
Joseph Catanzaro's Stock Ratings
Mizuho Analyst
Joseph Catanzaro is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
26.0%
Smart Score
Overall Average Return Percentile
82nd
Number of Ratings
148
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/17/2026 | TNGX | Buy Now | Tango Therapeutics | $27.54 | 45.24% | $36 → $40 | Maintains | Outperform | Get Alert | |
| 07/16/2026 | KYMR | Buy Now | Kymera Therapeutics | $110.72 | 26.45% | $120 → $140 | Maintains | Outperform | Get Alert | |
| 07/13/2026 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 49.71% | $30 → $34 | Maintains | Outperform | Get Alert | |
| 07/13/2026 | SYRE | Buy Now | Spyre Therapeutics | $97.33 | 23.29% | $84 → $120 | Maintains | Outperform | Get Alert | |
| 07/06/2026 | RVMD | Buy Now | Revolution Medicines | $180.39 | 19.19% | $185 → $215 | Maintains | Outperform | Get Alert | |
| 06/24/2026 | APGE | Buy Now | Apogee Therapeutics | $134.15 | 0.63% | $110 → $135 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/22/2026 | QTTB | Buy Now | Q32 Bio | $15.04 | -6.91% | → $14 | Initiates | → Outperform | Get Alert | |
| 05/15/2026 | TNGX | Buy Now | Tango Therapeutics | $27.54 | 8.93% | $20 → $30 | Maintains | Outperform | Get Alert | |
| 05/14/2026 | UPB | Buy Now | Upstream Bio | $6.98 | 616.33% | $51 → $50 | Maintains | Outperform | Get Alert | |
| 05/14/2026 | AVTX | Buy Now | Avalo Therapeutics | $18.21 | 147.12% | $39 → $45 | Maintains | Outperform | Get Alert | |
| 05/12/2026 | ERAS | Buy Now | Erasca | $18.82 | 38.15% | $28 → $26 | Maintains | Outperform | Get Alert | |
| 04/15/2026 | CLYM | Buy Now | Climb Bio | $12.90 | 39.53% | → $18 | Initiates | → Outperform | Get Alert | |
| 03/30/2026 | APGE | Buy Now | Apogee Therapeutics | $134.15 | -18% | $105 → $110 | Maintains | Outperform | Get Alert | |
| 03/23/2026 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | 234.26% | $10 → $12 | Maintains | Overweight | Get Alert | |
| 03/13/2026 | ERAS | Buy Now | Erasca | $18.82 | 0.96% | $16 → $19 | Maintains | Outperform | Get Alert | |
| 03/11/2026 | TNGX | Buy Now | Tango Therapeutics | $27.54 | -27.38% | $19 → $20 | Maintains | Outperform | Get Alert | |
| 03/02/2026 | EIKN | Buy Now | Eikon Therapeutics | $9.71 | 167.77% | → $26 | Initiates | → Outperform | Get Alert | |
| 02/23/2026 | TNGX | Buy Now | Tango Therapeutics | $27.54 | -31.01% | → $19 | Initiates | → Outperform | Get Alert | |
| 01/29/2026 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 54.12% | $32 → $35 | Maintains | Overweight | Get Alert | |
| 01/20/2026 | IBRX | Buy Now | ImmunityBio | $7.50 | -6.67% | $5 → $7 | Maintains | Overweight | Get Alert | |
| 01/20/2026 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | 178.55% | $6.5 → $10 | Maintains | Overweight | Get Alert | |
| 01/13/2026 | RVMD | Buy Now | Revolution Medicines | $180.39 | -20.73% | $90 → $143 | Maintains | Outperform | Get Alert | |
| 12/18/2025 | AVTX | Buy Now | Avalo Therapeutics | $18.21 | 114.17% | → $39 | Initiates | → Outperform | Get Alert | |
| 12/18/2025 | UPB | Buy Now | Upstream Bio | $6.98 | 630.66% | → $51 | Initiates | → Outperform | Get Alert | |
| 12/18/2025 | BCAX | Buy Now | Bicara Therapeutics | $27.15 | -33.7% | → $18 | Initiates | → Neutral | Get Alert | |
| 12/18/2025 | SYRE | Buy Now | Spyre Therapeutics | $97.33 | -45.55% | → $53 | Initiates | → Outperform | Get Alert | |
| 12/11/2025 | KYMR | Buy Now | Kymera Therapeutics | $110.72 | 8.38% | $81 → $120 | Maintains | Outperform | Get Alert | |
| 12/10/2025 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 32.1% | $24 → $30 | Maintains | Outperform | Get Alert | |
| 10/21/2025 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 5.68% | → $24 | Initiates | → Outperform | Get Alert | |
| 10/21/2025 | RVMD | Buy Now | Revolution Medicines | $180.39 | -50.11% | → $90 | Initiates | → Outperform | Get Alert | |
| 10/21/2025 | CLDX | Buy Now | Celldex Therapeutics | $35.42 | 35.52% | → $48 | Initiates | → Outperform | Get Alert | |
| 10/21/2025 | APGE | Buy Now | Apogee Therapeutics | $134.15 | -21.73% | → $105 | Initiates | → Outperform | Get Alert | |
| 10/21/2025 | KYMR | Buy Now | Kymera Therapeutics | $110.72 | -26.84% | → $81 | Initiates | → Outperform | Get Alert | |
| 10/10/2025 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 40.91% | $35 → $32 | Maintains | Overweight | Get Alert | |
| 05/20/2025 | IBRX | Buy Now | ImmunityBio | $7.50 | -33.33% | $4.25 → $5 | Upgrade | Neutral → Overweight | Get Alert | |
| 05/15/2025 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | 39.28% | $2.5 → $5 | Maintains | Overweight | Get Alert | |
| 04/14/2025 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | -30.36% | $3.25 → $2.5 | Maintains | Overweight | Get Alert | |
| 02/28/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 19.08% | $7.5 → $6 | Maintains | Neutral | Get Alert | |
| 02/27/2025 | SDGR | Buy Now | Schrodinger | $15.00 | 200% | $50 → $45 | Maintains | Overweight | Get Alert | |
| 02/13/2025 | MRUS | Buy Now | Merus | — | — | → $84 | Initiates | → Overweight | Get Alert | |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $132.94 | -17.26% | $105 → $110 | Maintains | Overweight | Get Alert | |
| 02/12/2025 | EXEL | Buy Now | Exelixis | $55.53 | -31.57% | $37 → $38 | Maintains | Overweight | Get Alert | |
| 01/31/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 48.85% | $10 → $7.5 | Maintains | Neutral | Get Alert | |
| 01/17/2025 | KROS | Buy Now | Keros Therapeutics | $10.61 | 41.38% | $40 → $15 | Maintains | Overweight | Get Alert | |
| 01/13/2025 | EXEL | Buy Now | Exelixis | $55.53 | -33.37% | $36 → $37 | Maintains | Overweight | Get Alert | |
| 01/10/2025 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -31.39% | $52 → $53 | Maintains | Neutral | Get Alert | |
| 12/13/2024 | CRDF | Buy Now | Cardiff Oncology | $0.84 | 1084.97% | $7 → $10 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | RVMD | Buy Now | Revolution Medicines | $180.39 | -61.2% | $57 → $70 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $132.94 | -21.02% | $95 → $105 | Maintains | Overweight | Get Alert | |
| 11/04/2024 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -32.69% | $51 → $52 | Maintains | Neutral | Get Alert | |
| 11/04/2024 | EPIX | Buy Now | ESSA Pharma | — | — | $15 → $2 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/31/2024 | BMEA | Buy Now | Biomea Fusion | $1.25 | 1420% | $10 → $19 | Maintains | Overweight | Get Alert | |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $55.53 | -35.17% | $33 → $36 | Maintains | Overweight | Get Alert | |
| 10/07/2024 | IMTX | Buy Now | Immatics | $9.23 | 105.85% | → $19 | Initiates | → Overweight | Get Alert | |
| 09/23/2024 | BDTX | Buy Now | Black Diamond Therapeutic | $1.80 | 733.33% | $12 → $15 | Maintains | Overweight | Get Alert | |
| 09/11/2024 | GILD | Buy Now | Gilead Sciences | $132.94 | -28.54% | $95 → $95 | Maintains | Overweight | Get Alert | |
| 08/27/2024 | AADI | Buy Now | Aadi Bioscience | — | — | $5 → $1.75 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/19/2024 | TSBX | Buy Now | Turnstone Biologics | — | — | $20 → $3.75 | Maintains | Overweight | Get Alert | |
| 08/19/2024 | IBRX | Buy Now | ImmunityBio | $7.50 | -36.67% | $6 → $4.75 | Maintains | Neutral | Get Alert | |
| 08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $4.96 | 625.81% | $36 → $36 | Maintains | Overweight | Get Alert | |
| 07/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 98.47% | $19 → $10 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/08/2024 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $40 → $40 | Maintains | Overweight | Get Alert | |
| 07/03/2024 | BDTX | Buy Now | Black Diamond Therapeutic | $1.80 | 566.67% | $12 → $12 | Maintains | Overweight | Get Alert | |
| 06/14/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.71 | 72.22% | $15 → $15 | Maintains | Overweight | Get Alert | |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $1.25 | 700% | $45 → $10 | Maintains | Overweight | Get Alert | |
| 06/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -33.98% | $48 → $51 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/05/2024 | NRIX | Buy Now | Nurix Therapeutics | $22.71 | 54.12% | $35 → $35 | Maintains | Overweight | Get Alert | |
| 05/28/2024 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | -2.51% | $2.25 → $3.5 | Upgrade | Neutral → Overweight | Get Alert | |
| 05/16/2024 | CNTX | Buy Now | Context Therapeutics | $0.62 | 625.92% | → $4.5 | Initiates | → Overweight | Get Alert | |
| 04/29/2024 | IBRX | Buy Now | ImmunityBio | $7.50 | -20% | $5 → $6 | Maintains | Neutral | Get Alert | |
| 04/25/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.74 | 1624.14% | $26 → $30 | Maintains | Overweight | Get Alert | |
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $2.44 | 719.67% | → $20 | Initiates | → Overweight | Get Alert | |
| 04/05/2024 | ACHL | Buy Now | Achilles Therapeutics | — | — | $8 → $2 | Downgrade | Overweight → Neutral | Get Alert | |
| 03/27/2024 | KROS | Buy Now | Keros Therapeutics | $10.61 | 889.63% | → $105 | Maintains | Overweight | Get Alert | |
| 03/27/2024 | LENZ | Buy Now | LENZ Therapeutics | $4.96 | 464.52% | → $28 | Initiates | → Overweight | Get Alert | |
| 03/26/2024 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $40 → $40 | Maintains | Overweight | Get Alert | |
| 03/25/2024 | IBRX | Buy Now | ImmunityBio | $7.50 | -33.33% | $4 → $5 | Maintains | Neutral | Get Alert | |
| 03/18/2024 | IMAB | Buy Now | I-MAB | — | — | $15 → $10 | Maintains | Overweight | Get Alert | |
| 03/14/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 277.09% | $18 → $19 | Maintains | Overweight | Get Alert | |
| 03/11/2024 | RVMD | Buy Now | Revolution Medicines | $180.39 | -76.16% | → $43 | Initiates | → Overweight | Get Alert | |
| 03/01/2024 | CRDF | Buy Now | Cardiff Oncology | $0.84 | 729.48% | $5 → $7 | Maintains | Overweight | Get Alert | |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $15.00 | 233.33% | $60 → $50 | Maintains | Overweight | Get Alert | |
| 02/28/2024 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $45 → $40 | Maintains | Overweight | Get Alert | |
| 02/26/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.71 | 72.22% | $10 → $15 | Maintains | Overweight | Get Alert | |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 257.24% | $14 → $18 | Maintains | Overweight | Get Alert | |
| 02/12/2024 | TNGX | Buy Now | Tango Therapeutics | $27.54 | -34.64% | → $18 | Initiates | → Overweight | Get Alert | |
| 12/27/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $10 | Downgrade | Overweight → Neutral | Get Alert | |
| 12/15/2023 | AADI | Buy Now | Aadi Bioscience | — | — | $30 → $5 | Maintains | Overweight | Get Alert | |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | $24 → $31 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/16/2023 | RPTX | Buy Now | Repare Therapeutics | — | — | $30 → $25 | Maintains | Overweight | Get Alert | |
| 10/10/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $58 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | — | — | → $20 | Initiates | → Overweight | Get Alert | |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $132.94 | -24.78% | $105 → $100 | Maintains | Overweight | Get Alert | |
| 07/14/2023 | BDTX | Buy Now | Black Diamond Therapeutic | $1.80 | 511.11% | → $11 | Initiates | → Overweight | Get Alert | |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $1.25 | 3500% | $40 → $45 | Maintains | Overweight | Get Alert | |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $1.56 | 12.18% | $15 → $1.75 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/12/2023 | IBRX | Buy Now | ImmunityBio | $7.50 | -46.67% | $10 → $4 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/10/2023 | EXEL | Buy Now | Exelixis | $55.53 | -49.58% | → $28 | Assumes | → Overweight | Get Alert | |
| 05/10/2023 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -40.45% | → $46 | Upgrade | Neutral → Overweight | Get Alert | |
| 05/05/2023 | SDGR | Buy Now | Schrodinger | $15.00 | 300% | → $60 | Assumes | → Overweight | Get Alert | |
| 05/05/2023 | KROS | Buy Now | Keros Therapeutics | $10.61 | 936.76% | $120 → $110 | Maintains | Overweight | Get Alert | |
| 05/03/2023 | IMGN | Buy Now | Immunogen | — | — | $6 → $16 | Upgrade | Neutral → Overweight | Get Alert | |
| 04/28/2023 | GILD | Buy Now | Gilead Sciences | $132.94 | -21.02% | → $105 | Assumes | → Overweight | Get Alert | |
| 04/03/2023 | IMAB | Buy Now | I-MAB | — | — | $30 → $25 | Maintains | Overweight | Get Alert | |
| 03/28/2023 | BMEA | Buy Now | Biomea Fusion | $1.25 | 3100% | $16 → $40 | Maintains | Overweight | Get Alert | |
| 01/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 177.85% | $11 → $14 | Upgrade | Neutral → Overweight | Get Alert | |
| 01/09/2023 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $40 → $45 | Maintains | Overweight | Get Alert | |
| 12/20/2022 | CPRX | Buy Now | Catalyst Pharmaceuticals | $31.48 | -36.47% | $18 → $20 | Maintains | Overweight | Get Alert | |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $1.74 | 1336.78% | → $25 | Initiates | → Overweight | Get Alert | |
| 12/07/2022 | ACHL | Buy Now | Achilles Therapeutics | — | — | $10 → $8 | Maintains | Overweight | Get Alert | |
| 11/21/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 118.31% | $13 → $11 | Maintains | Neutral | Get Alert | |
| 11/08/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | $15 → $11 | Downgrade | Overweight → Neutral | Get Alert | |
| 09/13/2022 | CRDF | Buy Now | Cardiff Oncology | $0.84 | 492.49% | $7 → $5 | Maintains | Overweight | Get Alert | |
| 08/30/2022 | IMAB | Buy Now | I-MAB | — | — | $35 → $30 | Maintains | Overweight | Get Alert | |
| 08/11/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $9 → $7 | Maintains | Overweight | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $3.59 | -58.22% | $10 → $1.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/21/2022 | DAWN | Buy Now | Day One Biopharmaceutical | — | — | $35 → $40 | Maintains | Overweight | Get Alert | |
| 06/02/2022 | RPTX | Buy Now | Repare Therapeutics | — | — | $25 → $30 | Maintains | Overweight | Get Alert | |
| 05/27/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 158.01% | $20 → $13 | Maintains | Neutral | Get Alert | |
| 05/12/2022 | EPIX | Buy Now | ESSA Pharma | — | — | $50 → $20 | Maintains | Overweight | Get Alert | |
| 05/10/2022 | OCUL | Buy Now | Ocular Therapeutix | $8.71 | 83.7% | $20 → $16 | Maintains | Overweight | Get Alert | |
| 05/05/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $2.18 | -31.19% | $25 → $1.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 03/14/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $27 → $15 | Maintains | Overweight | Get Alert | |
| 03/10/2022 | SNSE | Buy Now | Sensei Biotherapeutics | — | — | $12 → $10 | Maintains | Overweight | Get Alert | |
| 03/02/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $30 → $25 | Maintains | Overweight | Get Alert | |
| 09/08/2021 | AADI | Buy Now | Aadi Bioscience | — | — | → $45 | Initiates | → Overweight | Get Alert | |
| 06/21/2021 | FIGS | Buy Now | FIGS | $10.26 | 241.13% | → $35 | Initiates | → Overweight | Get Alert | |
| 05/20/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $5.04 | 257.24% | $35 → $18 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/18/2021 | RAIN | Buy Now | Rain Oncology | $1.56 | 1502.56% | → $25 | Initiates | → Overweight | Get Alert | |
| 05/11/2021 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -37.87% | $50 → $48 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/11/2021 | BMEA | Buy Now | Biomea Fusion | $1.25 | 2060% | → $27 | Initiates | → Overweight | Get Alert | |
| 04/26/2021 | ACHL | Buy Now | Achilles Therapeutics | — | — | → $25 | Initiates | → Overweight | Get Alert | |
| 03/25/2021 | MRKR | Buy Now | Marker Therapeutics | $1.45 | 313.79% | → $6 | Initiates | → Overweight | Get Alert | |
| 03/01/2021 | SNSE | Buy Now | Sensei Biotherapeutics | — | — | → $25 | Initiates | → Overweight | Get Alert | |
| 02/25/2021 | IMAB | Buy Now | I-MAB | — | — | → $75 | Initiates | → Overweight | Get Alert | |
| 02/12/2021 | SGEN | Buy Now | Seagen | — | — | $175 → $170 | Maintains | Neutral | Get Alert | |
| 10/08/2020 | CRDF | Buy Now | Cardiff Oncology | $0.84 | 2862.44% | → $25 | Initiates | → Overweight | Get Alert | |
| 08/06/2020 | IMMU | Buy Now | Immunomedics | — | — | $55 → $60 | Maintains | Overweight | Get Alert | |
| 07/24/2020 | SGEN | Buy Now | Seagen | — | — | $155 → $165 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/14/2020 | RPTX | Buy Now | Repare Therapeutics | — | — | → $40 | Initiates | → Overweight | Get Alert | |
| 07/08/2020 | NK | Buy Now | NantKwest | — | — | → $18 | Initiates | → Overweight | Get Alert | |
| 07/02/2020 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -59.87% | $28 → $31 | Maintains | Overweight | Get Alert | |
| 04/23/2020 | IMMU | Buy Now | Immunomedics | — | — | $30 → $40 | Maintains | Overweight | Get Alert | |
| 04/07/2020 | XBIT | Buy Now | XBiotech | $2.33 | 672.53% | $28 → $18 | Maintains | Overweight | Get Alert | |
| 03/05/2020 | OCUL | Buy Now | Ocular Therapeutix | $8.71 | 26.29% | $7 → $11 | Reiterates | → Overweight | Get Alert | |
| 02/05/2020 | HALO | Buy Now | Halozyme Therapeutics | $77.25 | -65.05% | $18 → $27 | Upgrade | Neutral → Overweight | Get Alert | |
| 12/11/2019 | XBIT | Buy Now | XBiotech | $2.33 | 1101.72% | $16 → $28 | Maintains | Overweight | Get Alert | |
| 09/30/2019 | SGEN | Buy Now | Seagen | — | — | $75 → $95 | Maintains | Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved